Zofran was brought to the United States market in 1991 by GlaxoSmithKline (GSK). The drug was originally certified for use by the FDA in the same year to be used as part of treatment for cancer patients going through chemotherapy, and those experiencing nausea because of a surgical procedure they’ve undergone. However, GSK strayed and did not stay within the FDA certified lines of the drug’s uses and promoted Zofran to OB/GYNs as a drug they can prescribe for relieving severe nausea and vomiting (NVM) in pregnant women. For this GSK plead guilty when this issue was brought to the Department of Justice, and paid $3 billion as part of an allegation of illegally giving doctors ‘kick-backs’. Read about the case here.
There have been several studies performed that have associated Zofran with a child’s chances of being born with a birth defect being higher if the mother took Zofran in the first 12 weeks of pregnancy. GSK knew of two occasions of birth abnormalities in 1991 involving mothers who used Zofran for NVM in their first 12 weeks of pregnancy. As the years went on more cases were reported to GSK about Zofran causing birth abnormalities. GSK was aware of the dangers their drug posed to unborn babies, therefore, lawsuits are being filed against the pharmaceutical giant.
Kansas Birth Abnormalities Data
More than 120,000 babies are born with a birth abnormality (approximately 1 in every 33 live births) each year America. In Kansas there are 1,250 cases of birth abnormalities each year. In 2014 the population for Kansas was pegged at 2,904,021. Below are the figures of the five major cities by inhabitants in Kansas:
- Wichita- 388,413 population
- Overland Park- 184,525 population
- Kansas City- 149,636 population
- Olathe- 133,062 population
- Topeka- 127,215 population
The U.S. availability of Zofran in 1991 saw the drug gain so much popularity that it became a drug with the most written scripts in the country. So popular was the drug that it most likely had 99% market share by 2005. Going by this data our Zofran advocates have calculated the potential number of births that may have been affected by the presence of Zofran in the womb resulting in a baby born with an abnormality, as they averaged the risk ratios found in clinical studies. The end figure comes to about 1,460 births in Kansas that may have been affected by a mom consuming Zofran in her first trimester resulting in a baby being born with a defect.
Kansas Estimated Orofacial Cleft & Congenital Heart Deformities Linked To Zofran
Using the Kansas population of 2,904,021, our calculations show that there were, 270 babies born with orofacial cleft deformities and 1,190 born with congenital heart deformities. The five biggest cities in Kansas had the following estimates:
- Wichita- 232 total birth deformities with about 36 that were orofacial cleft deformities, and 196 congenital heart defects
- Overland Park- 136 total birth deformities with about 17 that were orofacial cleft deformities, and 119 congenital heart defects
- Kansas City- 120 total birth deformities with about 14 that were orofacial cleft deformities, and 106 congenital heart defects
- Olathe- 112 total birth deformities with about 12 that were orofacial cleft deformities, and 100 congenital heart defects
- Topeka- 110 total birth deformities with about 12 that were orofacial cleft deformities, and 98 congenital heart defects
Cited Birth Defects Of Zofran
Zofran cases that have been brought to court have seen complainants cite that Zofran was the cause of serious birth abnormalities in instances where the mom took Zofran for morning sickness in the early stages of her pregnancy. These allegations are not unfounded as they are based off of the epidemiological studies that have been performed.
Some of the cited birth defects caused by Zofran are:
- Kidney malformations
- Cleft Palate
- Aortic arch hypoplasia
- Facial Dysmorphia
- Webbed Toes
- Low set ears
- Hearing loss
- Heart murmur
Kansas Parents Visiting ZofranLegal.com
Zofranlegal.com, was developed and funded by several law firms in order to provide up to the minute relevant news about the Zofran lawsuit. While our advocates are not licensed to practice law in Kansas, they are able to practice and are licensed in Delaware. Delaware is a viable state as it is where GSK has its headquarters, which means we are able to serve and file a lawsuit for your family from there. Go here for our Delaware contact information.
Families from Kansas have visited our website and made contact with us as they are of the understanding that their child has a Zofran induced birth abnormality. We completely understand that cases and situations will differ, therefore, we have various options to file your case. Your case can either be filed in Delaware or another location, or it can be filed through our approved local Kansas legal counsel.
For all the questions you may have, we are available to respond to them. Please get in touch with us any time of the day and night.
Where To Get Cleft Palate and CHDs Facts In Kansas
Visit the following websites we have compiled specifically for Kansas parents in need of support.